2-[(4-bromophenyl)methylsulfonyl]-N-[3-[(2-fluorophenyl)methyl]-1,3-thiazol-2-ylidene]acetamide
C19H16BrFN2O3S2 — CID 112827187
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(4-bromophenyl)methylsulfonyl]-N-[3-[(2-fluorophenyl)methyl]-1,3-thiazol-2-ylidene]acetamide
2-[(4-bromophenyl)methylsulfonyl]-N-[3-[(2-fluorophenyl)methyl]-1,3-thiazol-2-ylidene]acetamide (PubChem CID 112827187) has the molecular formula C19H16BrFN2O3S2 and a molecular weight of 483.38 g/mol. Its IUPAC name is 2-[(4-bromophenyl)methylsulfonyl]-N-[3-[(2-fluorophenyl)methyl]-1,3-thiazol-2-ylidene]acetamide.
Molecular Properties
| Compound Name | 2-[(4-bromophenyl)methylsulfonyl]-N-[3-[(2-fluorophenyl)methyl]-1,3-thiazol-2-ylidene]acetamide |
|---|---|
| PubChem CID | 112827187 |
| Molecular Formula | C19H16BrFN2O3S2 |
| Molecular Weight | 483.38 g/mol |
| Exact Mass | 481.98 |
| IUPAC Name | 2-[(4-bromophenyl)methylsulfonyl]-N-[3-[(2-fluorophenyl)methyl]-1,3-thiazol-2-ylidene]acetamide |
| SMILES | O=C(CS(=O)(=O)Cc1ccc(Br)cc1)/N=c1\sccn1Cc1ccccc1F |
| InChI | InChI=1S/C19H16BrFN2O3S2/c20-16-7-5-14(6-8-16)12-28(25,26)13-18(24)22-19-23(9-10-27-19)11-15-3-1-2-4-17(15)21/h1-10H,11-13H2/b22-19- |
| InChIKey | CGMHQIRLAYOETF-QOCHGBHMSA-N |
| XLogP | 3.54 |
| TPSA | 68.50 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 483.38 |
| LogP ≤ 5 | 3.54 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 112827187 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.